Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1737 of 6351
-
Magic mushroom compound targets Depression's blahs in small trial
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder.
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a classroom curriculum stop child sex trafficking? large trial launches
Prevention Recruiting nowThe overall goal of the five-year project is to conduct both a process and rigorous outcome evaluation of The Set Me Free Project (SMFP)'s READY to Stand (RTS)© curriculum with an eye toward widespread dissemination to other U.S. communities, if deemed effective. Broadly, the inv…
Sponsor: University of Michigan • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC
-
Heart-Brain link: major study seeks hidden causes of learning delays in children with heart defects
Knowledge-focused Recruiting nowThe leading cause of birth defects, Congenital Heart Defects (CHD) affect 12 million people worldwide and 41,000 newborns/year in Europe. It's a major cause of life-long morbidity and mortality, and a crucial public health issue. More than 50% of childs born with critical CHD wil…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New tools aim to boost colonoscopy rates and prevent cancer
Prevention By invitation onlyComplete and timely colonoscopy after an abnormal stool-based colorectal cancer screening test results in early detection, cancer prevention, and reduction in mortality, but follow-up in safety-net health systems occurs in less than 50% at 6 months. The proposal will implement mu…
Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control CompletedThis is a first-in-human, Phase 1a/1b study to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of BGB-C354 alone and in combination with tislelizumab in participants with advanced solid tumors. Study details include: * The study will be c…
Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for kids with joint pain: risankizumab trial launches
Disease control Recruiting nowPsoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time. PsA that begins before a patient's 16th birthday is c…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Virtual therapy aims to help Tube-Fed children with tracheostomies eat on their own
Disease control OngoingThe overall objective of this proposal is to test an interdisciplinary intervention to support the transition to oral feeding for children with feeding tubes and tracheostomies. The investigators' model which combines in-home clinical assessments with virtual therapies may maximi…
Sponsor: University of Chicago • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New membrane could speed healing of eye infections
Disease control CompletedThis study aims to evaluate the effectiveness of a specialized amniotic membrane preparation as an adjuvant therapy for patients with moderate-to-severe infected corneal ulcers. The specialized membrane contains a combination of Riboflavin and Moxifloxacin, which is applied duri…
Phase 2 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug cocktail targets tough KRAS G12D cancers in early trial
Disease control OngoingThe study is being conducted to evaluate the safety, tolerability, and efficacy of HRS-4642 in combination with antitumor medicine in patients with advanced solid tumors harboring KRAS G12D mutation.
Phase 1/2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 19:02 UTC
-
New hope for low blood counts after CAR T-Cell therapy?
Disease control Recruiting nowTo look at the safety and effectiveness of emapalumab for the treatment of prolonged severe cytopenia in participants with LBCL who receive CART.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Artificial intelligence reads CT scans to forecast pancreatic cancer prognosis
Diagnosis CompletedThis study describes the development and validation of a deep learning prediction model, which extracts deep learning features from preoperative enhanced CT scans and analyzes postoperative pathological specimens of pancreatic cancer patients. The aim is to predict patient progno…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Experimental combo aims to tackle Hard-to-Treat prostate cancer
Disease control Recruiting nowCarrying out clinical trials of salbutamol hydrochloride combined with immunotherapy and castration for the treatment of prostate cancer is of great significance. Firstly, it can verify the efficacy and safety of this combination in the treatment of prostate cancer, providing a s…
Phase 2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New mRNA shingles shot shows promise in early trial
Vaccine CompletedThe study will evaluate the safety, tolerability, and immunogenicity (your immune system's reaction) of the study vaccine called Herpes Zoster IN001 mRNA Vaccine (IN001) in healthy participants who are between 50 and 69 years of age
Phase 1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 12:02 UTC
-
Parkinson's patients get new hope: group therapy targets anxiety and depression
Symptom relief CompletedIn addition to increasingly severe physical symptoms, Parkinson's can cause distressing mental health issues. These include anxiety, depression, and memory and thinking problems, caused by a combination of biological and psychological factors. They can be more disabling than phys…
Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could brain tumor patients stop seizure meds sooner?
Disease control Recruiting nowLevetiracetam is the commonly preferred anti-seizure medicine in patients with brain tumors. This drug has reduced the risk of seizure events occurring but is associated with a risk of side effects such as increased headache, drowsiness, loss of muscle coordination, and psycholog…
Phase 3 • Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for chinese patients with severe transplant complication: ruxolitinib trial launches
Disease control OngoingThe purpose of this study is to assess the efficacy and safety of ruxolitinib therapy in Chinese adults and adolescents (≥ 12 years old) with Grade II-IV steroid-refractory acute graft versus host disease (SR-aGvHD).
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Immune check could stop virus after lung transplants
Disease control Recruiting nowThe purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Freezing heart tissue during surgery could stop atrial fibrillation
Disease control Recruiting nowThe study involves endocardial cryoablation of the left and/or right atrium of the heart using the CoolCryo system as an adjunct to mitral valve surgery, with the aim of eliminating atrial fibrillation (AF), which is a common sequelae of mitral valve defects and is associated wit…
Sponsor: Medinice S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for Hard-to-Treat cancers: first human trial begins
Disease control Recruiting nowA First-in-Human, Open Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of FZ-AD005 in Patients with Advanced Solid Tumors.
Phase 1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
AI stethoscope could spot heart valve trouble in minutes
Diagnosis Recruiting nowThe goal of this observational study is to evaluate accuracy of portable electronic stethoscope and machine learning-based diagnostic algorithms for detecting the disease in people with valvular heart disease and healthy controls. The main question it aims to answer is: Is porta…
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC